ACRS

$0.00

(

0.00%

)
Quote details

stock

Aclaris Therapeutics Inc

NASDAQ | ACRS

2.08

USD

$0.00

(

0.00%

)

At Close (As of Sep 8, 2025)

$227.50M

Market Cap

-

P/E Ratio

-1.57

EPS

$5.17

52 Week High

$1.05

52 Week Low

HEALTHCARE

Sector

ACRS Chart

Recent Chart
Price Action

ACRS Technicals

Tags:

ACRS Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $16M
Total Revenue $19M
Cost Of Revenue $2.8M
Costof Goods And Services Sold $2.8M
Operating Income -$142M
Selling General And Administrative $22M
Research And Development $34M
Operating Expenses $158M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $807K
Income Before Tax -$132M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$132M
Comprehensive Income Net Of Tax -
Ebit -$53M
Ebitda -$52M
Net Income -$132M

Revenue & Profitability

Earnings Performance

ACRS Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $220M
Total Current Assets $126M
Cash And Cash Equivalents At Carrying Value $25M
Cash And Short Term Investments $25M
Inventory -
Current Net Receivables $318K
Total Non Current Assets $94M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $90M
Short Term Investments $89M
Other Current Assets $12M
Other Non Current Assets -
Total Liabilities $65M
Total Current Liabilities $32M
Current Accounts Payable $4.7M
Deferred Revenue -
Current Debt -
Short Term Debt $962K
Total Non Current Liabilities $33M
Capital Lease Obligations -
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.6M
Other Current Liabilities $22M
Other Non Current Liabilities $13M
Total Shareholder Equity $156M
Treasury Stock -
Retained Earnings -$903M
Common Stock $1K
Common Stock Shares Outstanding $77M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$20M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $807K
Capital Expenditures $121K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$70M
Cashflow From Financing $75M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$132M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $16M
Total Revenue $19M
Cost Of Revenue $2.8M
Costof Goods And Services Sold $2.8M
Operating Income -$142M
Selling General And Administrative $22M
Research And Development $34M
Operating Expenses $158M
Investment Income Net -
Net Interest Income -
Interest Income -
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $807K
Income Before Tax -$132M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$132M
Comprehensive Income Net Of Tax -
Ebit -$53M
Ebitda -$52M
Net Income -$132M

ACRS News

ACRS Profile

Aclaris Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a line of novel small molecule therapeutics to address the needs of patients with immuno-inflammatory diseases. The company is headquartered in Wayne, Pennsylvania.

NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-1.02%
$18.43
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
YAAS
-21.16%
$0.08
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
T
-2.33%
$28.90
MGIH
+42.13%
$2.25
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
NCLH
-4.40%
$24.53
GOOGL
-0.31%
$234.04
WULF
+0.76%
$9.19
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
NOK
+0.87%
$4.59
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
PT
+17.89%
$1.12
RIG
+2.93%
$3.16
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.50%
$16.79
RGTI
+0.33%
$15.15
CRWV
+5.00%
$93.55
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
MULN
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
QBTS
+0.32%
$15.42
ITUB
-0.70%
$7.05
NXTT
+2.79%
$0.15
SKYQ
+73.45%
$0.72
OCTO
+3008.96%
$45.08
CGBS
-39.47%
$0.03
GNPX
-10.37%
$0.20
XAIR
+49.77%
$3.31
NVDA
+0.77%
$168.31
SOUN
+7.22%
$15.29
QS
+21.04%
$9.49
HOOD
+15.83%
$117.28
SNAP
-1.23%
$7.22
AAL
-0.99%
$12.95
NIO
+3.69%
$6.17
SNTG
+237.12%
$6.81
IXHL
+10.83%
$0.58
TSLA
-1.26%
$346.40
TLPH
+49.12%
$0.81
ABEV
-1.34%
$2.20
TPIC
-45.91%
$0.12
NFE
-42.85%
$1.40
AXDX
-61.36%
$0.03
HOUR
+56.16%
$5.70
RAYA
-12.69%
$0.03
WBD
+1.98%
$12.35
MARA
+0.06%
$15.20
DNN
+1.27%
$2.38
KVUE
-1.02%
$18.43
SOFI
+1.40%
$25.96
TLRY
-5.88%
$1.12
BTG
+2.87%
$4.29
RIVN
-1.54%
$13.99
LYT
-16.77%
$0.09
ONDS
+7.63%
$6.06
KEY
+1.10%
$19.14
ACRV
+34.58%
$1.79
INTC
-0.04%
$24.48
HL
+12.19%
$10.11
NVVE
+16.64%
$0.26
PFE
-1.32%
$24.55
AAPL
-0.75%
$237.88
YAAS
-21.16%
$0.08
BAC
-0.62%
$49.46
PLTR
+1.95%
$156.10
LDI
+31.83%
$3.81
CPNG
+8.95%
$31.50
MBOT
+22.95%
$4.50
ILLR
+22.34%
$0.52
AVGO
+3.21%
$345.65
VHAI
0.00%
$0.00
RIOT
+1.12%
$13.44
AMD
+0.17%
$151.41
T
-2.33%
$28.90
MGIH
+42.13%
$2.25
RMBL
+60.50%
$3.21
F
-0.42%
$11.69
AIRE
+16.00%
$0.47
BBD
-0.94%
$3.15
ADD
-25.47%
$0.05
RR
+17.78%
$2.98
BMNR
+4.16%
$43.79
CMG
-3.43%
$39.65
HIMS
+2.54%
$49.64
KDP
-3.56%
$27.63
SRM
+53.27%
$10.30
AMZN
+1.51%
$235.84
GRAB
+0.58%
$5.19
HBAN
+0.56%
$17.73
NCLH
-4.40%
$24.53
GOOGL
-0.31%
$234.04
WULF
+0.76%
$9.19
PLUG
-1.36%
$1.44
PCG
-3.51%
$14.56
NOK
+0.87%
$4.59
VZ
-2.38%
$43.32
CUTR
-10.19%
$0.09
PET
-59.91%
$0.04
CDT
-32.44%
$0.79
ADAP
+3.65%
$0.04
WLGS
-5.57%
$0.04
CIFR
+2.65%
$7.72
PT
+17.89%
$1.12
RIG
+2.93%
$3.16
ETWO
0.00%
$3.30
JOBY
-0.22%
$13.43
INFY
+2.50%
$16.79
RGTI
+0.33%
$15.15
CRWV
+5.00%
$93.55
SATS
+19.91%
$80.63
IREN
+0.15%
$26.19
AFMD
-34.94%
$0.18
ETHD
+1.96%
$3.63
BINI
-17.38%
$0.14
MULN
-17.38%
$0.14
AGNC
-0.28%
$10.34
SBET
+4.92%
$15.67
GOOG
-0.34%
$234.16
NBIS
-2.15%
$64.06
DVLT
+5.57%
$0.32
QBTS
+0.32%
$15.42
ITUB
-0.70%
$7.05

Charts powered by TradingView


Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.